Drug Type Molecular glue |
Synonyms Domatinostat/Sirolimus + [1] |
Target |
Mechanism HDAC inhibitors(Histone deacetylase inhibitors), KDM1A inhibitors(Lysine-specific histone demethylase 1 inhibitors), mTOR inhibitors(Serine/threonine-protein kinase mTOR inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Vuja De Sciences, Inc.Startup |
Active Organization Vuja De Sciences, Inc.Startup |
Inactive Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Osteosarcoma | IND Approval | US | Vuja De Sciences, Inc.Startup | 01 Oct 2024 |